Dong-A to launch biosimilar plant in Songdo

Published: 2011-10-04 06:57:00

Updated: 2011-10-04 06:57:00

Dong-A Pharmaceutical Co., the nation’s No.1 drug maker, said Thursday that it signed a memorandum of understanding (MOU) with Incheon Free Economic Zone (IFEZ) Authority to build and operate a a global biomedicine complex including a biosimilar plant in Songdo, some 30 kilometers west of Seoul n...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK